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Background: Sperm motility is a critical factor in male fertility. Low motility can be caused by a variety factors
including abnormal spermatogenesis, oxidative damage, or depletion of intracellular ATP. Recent findings indicate
that hydrogen molecule (H2) selectively reduces toxic reactive oxygen species. In this study, we investigated the
effects of H2 on human sperm motility in vitro.
Methods: Experimentally damaged sperm suspensions from patients left at room temperature for > 5 days or
frozen immediately after ejaculation were used. After exposure with H2, their forward motility was measured with a
counting chamber. A time-lapse movie was recorded to analyze sperm swimming speed. Mitochondria were
stained with a membrane potential-sensitive dye.
Results: H2 treatment significantly improved the rate of forward motility, whereas treatment with nitrogen gas did
not. While treatment for 30 min was sufficient to improve motility, it did not affect sperm swimming speed. After
24 h, retreatment with H2 increased the motility again. H2 treatment also increased mitochondrial membrane
potential. Forward motility of low motile frozen-thawed sperm from patients significantly improved with cleavage
medium containing H2.
Conclusions: Our results illustrated that H2 treatment stimulates low sperm motility. H2 is a new promising tool for
male infertility treatments.
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Several factors are present in infertile males with sperm
function defects caused by asthenozoospermia [1]. Gene
defects, including DNMT3B and MTHFR, have been
well documented to correlate with this phenotype [2].
Mitochondria DNA haplogroups may affect sperm mo-
tility [3]. Systemic disorders such as polycystic kidney
disease [4] also affect fertility and cause asthenozoospe-
rmia. Sperms are highly vulnerable to oxidative stress be-
cause they contain high concentrations of free unsaturated
fatty acids, lack intracellular antioxidant enzymes, and
have a limited capacity for DNA repair [5]. The precise
mechanisms of motility loss in the sperm, the ability of
this cell to fuse with the oocyte under oxidative stress,
and the subsequent initiation of lipid peroxidation are
not known [6]; however, both oxidative damage to the* Correspondence: iohsawa@tmig.or.jp
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be involved [7]. While mitochondria are crucial for ATP
production, they are also the main source of reactive
oxygen species (ROS), notably via the formation of
superoxide in the electron transport chain. Neverthe-
less, low levels of ROS are essential and act as second
messengers for the regulation of sperm functions [8].
Previous studies have examined the effects of seminal
plasma levels or oral administration of zinc, aspartic acid
or coenzyme Q10 on semen quality, and their effects
in vitro [9-11]. Especially, myoinositol and xanthine deri-
vates have turned out to be an effective tool in stimula-
tion of sperm motility [12,13]. We reported previously
that the hydrogen molecule (H2) dose-dependently re-
duces the hydroxyl radical (•OH) in vitro, whereas H2 is
too weak to reduce physiologically important ROS such
as NO• and superoxide [14]. H2, the smallest molecule
in the universe, has the unique ability of rapidly diffusing
across membranes; it can react with cytotoxic •OH in allThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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thus effectively protect cells against oxidative damage.
Indeed, H2 prevented a decrease in the cellular levels of
ATP synthesized in mitochondria [14]. Many studies
reported previously that H2 suppressed oxidative stress-
induced injury in several organs, reduced ischemia-
reperfusion injury in the brain, heart, liver, and retina
[14-17], protected against nephrotoxicity [18], and sup-
pressed radiation-induced acute injury in the lung [19].
In the present study, we used experimentally damaged
sperm suspensions, and investigated whether H2 treat-
ment exerts protective effects on human sperm. We fur-
ther demonstrated the practical application of H2
treatment of frozen-thawed sperm from patients.
Methods
Preparation of sperm suspensions
Human sperm suspensions from donors were used in
this study. This study was approved by the Institutional
Review Board of Yamashita Shonan Yume Clinic with
consent from patients receiving in vitro fertilization
(IVF) treatment at the Yamashita Shonan Yume Clinic.
All patients needed IVF and/or intracytoplasmic sperm
injection (ICSI) because they showed seminal defects
such as hypospermia, oligozoospermia and asthenozoos-
permia. All procedures followed were in accordance with
the ethical standards of the responsible committee on
human experimentation (institutional and national) and
with the Helsinki Declaration of 1964 and its later
amendments. Informed consent was obtained from all
patients for being included in the study.
Semen suspensions from patients, who were asked to
respect an ejaculatory abstinence period of 3–5 days,
were collected by masturbation. A part of them were im-
mediately frozen by the method described below. Sperm
parameters were assessed according to World Health
Organization criteria (2010) [20]. Collected samples were
prepared by washing semen in cleavage medium (SAGE
cleavage medium; CooperSurgical, CT, USA) supple-
mented with 10% plasma protein fraction (PPF; Baxter
Healthcare, IL, USA) to remove seminal plasma, centri-
fuging through a two-layer Percoll® density gradient at
600 × g for 15 min, concentrating by centrifugation at
400 × g for 5 min, and resuspending sperm in cleavage
medium with 10% PPF [21].
Treatment of experimentally damaged sperm with
hydrogen molecule
After IVF using sperm from patients, remaining sperms
for discard were used. Each experimentally damaged sperm
suspension left in room air at room temperature for > 5 days
was divided into three groups as follows: untreated (i.e.,
control), H2-treated, and N2-treated. During experiments,
sperm suspensions were kept in approximately atmosphericO2 concentration to enhance oxidative damage. A sperm
suspension of 100 μL on a culture dish was placed into an
exposure chamber (volume, approximately 5 L) with H2-
mixed gases (5% CO2, 20% O2, 50% H2, and 25% N2) or
N2-mixed gases (5% CO2, 20% O2, and 75% N2). After clos-
ing the exposure chamber tightly, these concentrations of
mixed gases (1 L/min flow rate) were reached within ap-
proximately 5 min. To confirm saturation of the sperm sus-
pensions with mixed gases, we monitored H2 and O2
concentrations with needle-type sensors (Unisense, Aarhus
N, Denmark). After exposure to mixed gases, each sperm
suspension was mixed well by pipetting and a 5–10 μL
drop was placed in a counting chamber [22]. The sperm
concentration, forward motility sperm rate, non-forward
motility sperm rate, and immobility sperm rate were mea-
sured visually three times for each sperm suspension.
To evaluate the velocities of motile sperm, a drop of the
suspension was placed in a counting chamber and time-
lapse movies of sperm movement were recoded using a
microscope (Olympus, Tokyo, Japan) for 10 s. Moving
images were processed with ImageJ and the CASA
(computer assisted sperm analysis) plugin [23]. Forward
motility sperm were selected to calculate the velocity.
Treatment of frozen-thawed sperm with hydrogen
molecule
Equal amount of freshly prepared sperm suspension
from 21 patients in cleavage medium and TEST-yolk
buffer (Irvine Scientific, CA, USA) were mixed and dis-
pended into cryotubes. After exposing to nitrogen steam
for 5 minutes, cryotubes were stocked in liquid nitrogen
[24]. To thaw frozen sperm solution, cryotubes were
warmed at 37°C for 5 min, and then each frozen-thawed
sperm suspension was dispensed into 4 vials. To prepare
the sperm-wash medium containing H2, a 50, 75 or
100% of cleavage medium saturated with H2 was mixed
with the medium equilibrated with 5% CO2. Sperm sus-
pensions were washed for 5 minutes with them, and
measured their motility.
Fluorescent staining of sperm mitochondria
Mitochondria were co-stained with MitoTracker Green
(MTG, 2 μM; Life Technologies, CA, USA) and tetra-
methylrhodamine methyl ester (TMRM, 2 μM; Life
Technologies) for 30 min. MTG fluorescence was inde-
pendent of the membrane potential; however, TMRM
fluorescence was dependent on the membrane potential.
MTG and TMRM were visualized with excitation at 488
and 543 nm, and emission at 510 and 565 nm with a
laser-scanning confocal microscope (Leica, Wetzlar,
Germany). Images were analyzed for the membrane po-
tential of individual sperm using TMRM fluorescence
intensity values [25]. Sperm viability was assessed by
staining with propidium iodine (PI, 10 μM; Dojindo,
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Dojindo). Stained sperm were visualized with excitation
at 535 and 350 nm, and emission at 617 and 461 nm
with a laser-scanning confocal microscope, respectively.
Statistical analysis
All statistical analyses were conducted with JMP (SAS,
NC, USA) and essentially performed using one-way
ANOVA followed by a post hoc Dunnett's test and two-
way ANOVA. Comparison of forward motility before
and after treatment of each sperm solution was per-
formed using the paired t-test. Differences between data
were considered significant for P-values < 0.05.
Results
Improvement of experimentally damaged sperm motility
by treatment with hydrogen molecule
To assess the effect of H2 on sperm motility, we first pre-
pared highly damaged sperms in vitro. Sperm suspensions
from patients were left at room temperature for > 5 days,
which enhanced oxidative stress and reduced sperm motil-
ity. The average of forward motility rate in 35 suspensions
was 3.6% [90% confidence interval (CI): 0.6-6.7%]. We
then treated the sperm suspensions with mixed gases con-
taining 50% H2 gas (H2-mixed gases) for 40 min and
found that the forward motility rate increased significantly
(16.8%, 90% CI: 13.8-19.9%) (Figure 1a). On the other
hand, the rate did not change (7.7%, 90% CI: 4.6-10.8%)
after the sperm suspensions were treated with N2-mixed
gases (without H2 gas). At that time, pH was almost equal
between suspensions treated with N2- and H2-mixed gases
(pH7.3 ± 0.1). Next, we examined the effect of treatment
duration using other suspensions with relatively higher
motility (n = 12). Both 30 and 60 min treatments with H2-
mixed gas significantly improved sperm motility, whereas
the 5 min treatment did not (Figure 1b), indicating that



















Figure 1 Effect of H2 treatment on human sperm motility. Damaged s
mixed gases for 40 min (a). Another sperm suspensions (n = 12) were treat
represented as means ± standard deviation (SD). ***P < 0.001, versus the unEffect of the sperm survival rate on H2 treatment
The survival rate of sperm is different in each patient
and affects the mobility [26]. We selected other sperm
suspensions from 30 patients and examined survival by
staining sperm with PI. The average percentage of PI-
negative, viable sperm in all suspensions was 18:6þ35:0−18:6 %.
We then divided them into two groups based on the per-
centage of viable sperm: high > 20% (n = 17, 35:6þ20:0−12:0 % )
and low < 20% (n = 13, 3:7þ9:3−3:7 % ). In low-viability group,
sperm were immobile before and after treatment with
mixed gases. However, we found that H2 treatment stimu-
lated a very sluggish motility of several sperms with pen-
dular movement of their heads around the axis of forward
motility in 3 out of 13 suspensions, indicating that almost
immobile sperm remaining a weak ability of movement
may be activated by H2 treatment. We further investigated
the effects of H2 treatment on sperm in high-viability
group, in which the average forward motility was 3.0%
(90.0% CI: 0.0-10.4%). After treatment with H2-mixed gas,
we found that the forward motility in 16 suspensions sig-
nificantly increased (Figure 2). Sperm motility in 4 suspen-
sions improved with both H2- and N2-mixed gases, except
for one suspension, which was not activated by both
mixed gases. The average forward motilities in sperm sus-
pensions after treatment with H2- and N2-mixed gases
were 11.0% (90% CI: 2.7-20.0%) and 3.6% (90% CI: 0.0-
17.6%), respectively. Thus, H2 treatment effectively and
significantly improved sperm motility in suspensions with
a higher survival rate.Effect of H2 treatment on sperm swimming speed
To examine the effect of H2 treatment on sperm swim-
ming speed, we used time-lapse microscopy and ana-
lyzed images with sperm analysis computer software,
CASA. Ten sperm suspensions, which were randomly
selected from 17 suspensions with a higher survival rateUntreated 5 30 60






perm suspensions (n = 35) were untreated or treated with H2- or N2-
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P = 0.3776P < 0.0001
Figure 2 Effect of H2 treatment on human sperm motility in
each suspension. Seventeen sperm suspensions with a sperm
viability rate > 20% were used. Sperm motility was determined
before and after treatment with H2- or N2-mixed gases for 30 min.
Sperm motility in 12 suspensions (dark blue) improved only with H2-
mixed gas, in 4 suspensions (light blue) improved with both H2- and
N2-mixed gases and in one suspension (pink) was not activated by




















Figure 3 Effect of H2 treatment on human sperm velocity. Ten
sperm suspensions were treated with H2- or N2-mixed gases for
30 min, and time-lapse movies of sperm motility were recorded
with a microscope for 10 s. No significant difference was observed
between control and treated groups. Data are represented as
means ± standard deviation (SD).
Figure 4 Retention time of sperm suspensions with improved
motility following H2 treatment. Twelve sperm suspensions were
treated with H2- or N2-mixed gases for 30 min (first treatment) and
then retreated after 24 h, (second treatment), as indicated by
hatching. Before and after the treatment, the suspension was kept at
25°C in room air. The average % of motile sperm per 1 mL of sperm
suspension at the indicated times was calculated. Data represent
means ± standard deviation (SD). ***P < 0.001; versus suspensions
just before treatment (time = 0).
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30 min, and traveling distances of only moving sperm
were measured for 10 s (Figure 3). No significant differ-
ence was observed between control and treated groups,
indicating that H2 treatment does not affect sperm
swimming speed.
Retention time of H2 treatment on sperm motility
The retention time of motile sperm treated with H2 is an
important indicator of IVF and ICSI success. After treat-
ment with H2- or N2-mixed gases for 30 min, 10 sperm
suspensions were kept at 25°C in room air. After 2.5 h, we
found that forward motility in H2 treated suspension was
still higher than that before treatment (Figure 4). It is
noteworthy that H2 quickly diffuses. Approximately
10 min after placing an aliquot of the H2-treated sperm
suspension in room air, the dissolved H2 concentration
reached < 0.1% of its saturated concentration, indicating
that the higher sperm motility enhanced by H2 treatment
can be maintained without H2 for at least 2.5 h.
After the first H2 treatment, we further kept a sperm
suspension at 25°C in room air for 24 h and found that
its motility still remained a level approximately 36% of
that of the first treatment (Figure 4). However, it was
not significantly higher than that before treatment. We
then treated this sperm suspension with H2 for 30 min
(second treatment) and kept it at 25°C in room air for
Nakata et al. Medical Gas Research  (2015) 5:2 Page 5 of 830 min, and found that sperm motility increased again,
reaching a level approximately 67% of that of the first
treatment.
Enhancement of mitochondrial membrane potential by
H2 treatment
Since sperm motility is dependent on ATP content, we
hypothesized that the improvement of sperm motility by
H2 treatment might be due to changes in mitochondrial
function. Therefore, after treatment with H2- or N2-
mixed gases for 30 min by the same method described
in Figures 1, 2 and 3, we stained sperm with TMRM, a
mitochondrial membrane potential-dependent dye, and
found that TMRM fluorescence increased (Figure 5),
suggesting that H2 treatment may enhance mitochon-






















Figure 5 Increase of mitochondrial membrane potential in
sperm suspensions by H2 treatment. Six sperm suspensions were
either untreated (a), or treated with H2- or N2-mixed gases (b and c,
respectively), and stained with MitoTracker Green (MTG) and TMRM
mitochondria- and mitochondrial membrane potential-sensitive
fluorescent dyes. Differential interference contrast (DIC) images are also
shown. Bars = 10 μm. The fluorescence intensity of each TMRM-stained
sperm was semi-quantitatively analyzed by ImageJ (d). Data represent
means ± SD. ***P < 0.001, versus the untreated sperm suspension.Improvement in frozen-thawed sperm motility by
treatment with hydrogen molecule
To demonstrate the practical application of H2, we pre-
pared frozen-thawed sperm suspension from each patient,
which could be used for infertility treatment. The average
forward motility of total 21 suspensions was 37.1% (95%
CI: 28.7-45.6). Asthenozoospermia was defined according
to the WHO guideline as samples with < 50% progressive
sperm motility [20]. Therefore, we divided them into two
groups, higher (forward motility ≥ 50%, n = 6) and lower
(<50%, n = 15) suspensions, of which the average forward
motilities before H2-treatment were 61.3% (95% CI: 50.8-
71.8%) and 27.5% (95% CI: 21.7-33.2%), respectively. All
suspensions were treated with sperm-wash media contain-
ing different concentrations (50, 75, and 100%) of H2.
Dunnett's t-test for unpaired values indicated that the
motility in suspensions of lower motile, asthenozoosper-
mic sperms significantly increased after treatment with
sperm-wash media containing 50% of H2, whereas treat-
ment with 75% and 100% of H2 did not (Figure 6a). H2-
treatment did not show any dose-dependency. The
motility both in total and suspensions of higher motile,
normozoospermic sperms did not significantly increase
after H2-treatment. Next, we compared the forward mo-
tility before and after treatment of each sperm suspen-
sion by using the paired t-test. The forward motility in
suspensions of higher motile sperms moderately in-
creased after H2-treatment (Figure 6b). Treatments with
75% of H2 significantly improved the motility of suspen-
sions, whereas treatments with 50% and 100% of H2 did
not. On the other hand, we found that the forward mo-
tility in suspensions of lower motile sperms apparently
increased after treatment with sperm-wash medium
containing both 50% and 75% of H2 (Figure 6c), whereas
treatment with 100% of H2 did not. These results indi-
cated that H2-treatment effectively and significantly im-
proved the motility of frozen-thawed sperms, especially
low motile, asthenozoospermic ones.
Discussion
Since previous studies have shown the balance between
ROS and antioxidants to be unequivocally important for
a variety of functions in the male reproductive system,
we hypothesized that H2 treatment may be protective as
a weak scavenger of ROS and may improve sperm motil-
ity in vitro. There are two reasons why sperm suspen-
sions left at room temperature for > 5 days were used.
Firstly, ejaculated sperm must be kept for 3 days at our
clinic for infertility treatments, and remaining sperms
for discard were used. Secondly, H2 is stable and must
be coaxed with strong catalysts to enter into chemical
reactions, and has been treated as an inactive gas in our
body, indicating the possibility that the effects of H2 on












































































Before  After Before  AfterBefore  After
50% of H2 75% of H2 100% of H2
Before  After Before  AfterBefore  After
50% of H2 75% of H2 100% of H2
P = 0.5000 P = 0.0240 P = 0.0581 P = 0.0048 P = 0.0025 P = 0.1613
Figure 6 Effect of H2 treatment on human frozen-thawed sperm motility in each suspension. Total frozen-thawed sperm suspensions
(n = 21) were divided into 2 groups, those with higher (forward motility≥ 50%, normozoospermic, n = 6) or lower (<50%, asthenozoospermic,
n = 15) motility. Sperm motility was determined before and after treatment with sperm-wash medium containing 50%, 75% and 100% of H2
for 30 min. Data represent means ± SD. *P < 0.05, versus the untreated sperm suspension (a). Comparison of forward motility before and after
treatment of each sperm suspension with higher (b) or lower (c) motility. P-values were determined using paired t-test.
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assess the effect of H2 on sperm motility.
The rate of forward motility increased from 3.6% to
16.8% (Figure 1a). The change in motility by H2 treat-
ment was higher than or similar to results previously
reported, e.g., 17.95% to 25.1% for treatment with
platelet-activating factor [27] and a 21% increase for ex-
ogenous pyruvate treatment [28]. Because the increase
of forward motility was observed within only 30 min, H2
treatment may stimulate cell signaling and activate mito-
chondria, but not transcription and translation in sperm.
However, it remains to be elucidated whether the stimu-
latory effects are dependent on a property of H2 as a re-
ductant. Furthermore, H2, but not N2, stimulated sperm
motility, indicating that the effect of H2 did not rely on
mechanical stimuli.
Effects were evident in almost all sperm suspensions
(16 out of 17) with higher survival rates in which anincrease of forward motility was observed with H2 treat-
ment (Figure 2). Slight increase of the motility treated
with N2 may due to the effect of mixing and shaking of
sperm suspension during experimental manipulation
[29]. The samples used in this study were collected from
various patients with different physiological conditions
and genetic backgrounds; therefore, it is possible that
the effects of H2 rely on the character of each sperm
suspension. The lack of response in forward motility in
sperm suspensions with low survival rates indicated that
H2 treatment was less effective on complete or nearly
complete necrozoospermia. However, we found that H2
treatment stimulated a very sluggish motility of several
sperms in 3 out of 13 suspensions with low survival
rates, further indicating that H2 is beneficially effective
on movement of sperms with both high and low sur-
vival rates. The differential effects of H2 treatment may
be dependent on various conditions of sperm.
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(Figure 3), indicating that H2 did not hyperactivate sperm.
Hyperactivation is characterized by a more energetic and
less symmetric beat of sperm flagella and can be achieved
in vitro by seminal plasma removal and incubation of
sperm in capacitating medium. However, several reagents,
including caffeine, which can stimulate sperm movement,
have no effect on sperm velocity [30]. On the other hand,
exogenous pyruvate accelerates glycolysis, and stimu-
lates motility and hyperactivation with an increase in
intracellular ATP levels [28]. It has been reported that
glucose-derived ATP during capacitation involves hy-
peractivation [31], indicating that H2 treatment does
not affect glycolysis.
We found that the higher sperm motility induced by
H2 treatment was maintained for 2.5 h, even in the ab-
sence of H2 (Figure 4), which is clinically enough time
for IVF and ICSI. The decrease in motility after H2 treat-
ment is due to several reasons, including the reduction
of intracellular ATP, and oxidative stress of oxygen in
the room air [32]. Nevertheless, the motility increased
the following day after a second H2 treatment. The in-
crease of motility with second treatment of H2 was still
higher than that of N2, indicating that the repeated in-
crease was due to H2, but not mechanical stimuli. The
repeated stimulation of sperm is likely to be useful in a
clinical setting. Higher variation of the mobility in H2-
treated sperm in Figure 4 may be dependent on its
higher mobility, because the difference of coefficients of
variation between the mobility of H2-treated sperm (0.26
to 0.59%) and that of N2 (0.48 to 0.98%) was very low.
A functional relationship among sperm mitochondrial
membrane potential, sperm motility, and fertility poten-
tial has been proposed [33]. We found that H2 treatment
enhanced mitochondrial membrane potential (Figure 5).
Since sperm motility is dependent on ATP content, we
speculate that H2 treatment enhances mitochondrial
function, promotes ATP production, and then stimulates
sperm motility. Indeed, we observed previously that H2
prevented a decrease in cellular levels of ATP synthe-
sized in mitochondria [14]. Precise measurements of
both ATP and calcium in sperm are needed before and
after treatment with H2.
Finally, we used frozen-thawed sperm suspensions to val-
idate the effects of H2 treatment on the motility of damaged
sperm. Frozen sperm suspension is used routinely in
assisted reproduction treatment. However, freezing has
been reported to cause changes in sperm morphology, in-
cluding damage to mitochondria. Sperm motility is particu-
larly sensitive to freezing damage [34,35]. Effects were
evident in 13 out of 15 suspensions of low motile frozen-
thawed sperm (86.7%) in which an increase of forward mo-
tility was observed with sperm-wash medium containing
50% of H2 (Figure 6b), indicating that H2 treatment isclinically a potential approach to activate low motility
sperm. However, treatment with medium containing higher
concentration, 100%, of H2 was not effective, indicating the
possibility that very low concentration of O2 in the medium
might repress the sperm motility [36]. Further study is
needed to elucidate a dose-dependency of H2-treatment.
The fertilization rates after IVF and ICSI using normal
sperm are approximately 60% and 70%, respectively [37].
In general, the decision to perform either IVF or ICSI is
dependent on sperm quality [38], which is determined by
the total number of motile sperm [39]. While the concen-
tration and morphology of ejaculated sperm do not affect
ICSI results, the injection of a completely immotile sperm-
atozoon is likely to have a negative effect on fertilization
and the pregnancy rate [21,40]. Currently, there is no effi-
cient therapy for asthenozoospermia.Conclusion
The findings of this study strongly indicate that H2 treat-
ment activates low motility sperms. Importantly, recent
studies demonstrated that H2 might have potential for
wide use in medical applications as a novel, safe, effect-
ive antioxidant with minimal side effects [14-19]. We
propose here that H2 is a new promising agent for male
infertility treatment. However, to make practical use of
H2 treatment, we further need to examine the effects of
H2-treated sperm on fertilizing ability, embryonic devel-
opment and safety for IVF and ICSI in future studies.
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